PDF下载 ( 177 KB)
Noninvasive assessment of nonalcoholic fatty liver disease
-
-
[1]Amarapurkar DN, Hashimoto E, Lesmana LA, et al., Howcommon is non-alcoholic fatty liver disease in Asia-Pacific region and are there local differences[J].J Gastroenterol Hepatol, 2007, 22 (6) :788-793. [2]Fan JG, Zhu J, Li XJ, et al.Fatty liver and the metabolic syndrome among Shanghai adults[J].J Gastroenterol Hepatol, 2005, 20 (12) :1825-1832. [3]Chan HLY, de Silva HJ, Leung NWY, et al.How should we man-age patients with non-alcoholic fatty liver disease in2007-[J].J Gastroenterol Hepatol, 2007, 22 (6) :801-808. [4]Matteoni CA, Younossi ZM, Gramlich T, et al.Nonalcoholic fatty liver disease:a spectrum of clinical and pathological severity[J].Gastroenterology, 1999, 116 (6) :1413-1419. [5]Farrell GC, Chitturi S, Lau GKK, et al.Guidelines for the assess-ment and management of non-alcholic fatty liver disease in the Asia-Pacific region:Executive summary[J].J Gastroenterol Hepatol, 2007, 22 (6) :801-808. [6]Saadeh S, Younossi ZM, Remer EM, et al.The utility of radiologi-cal imaging in nonalcoholic fatty liver disease[J].Gastroenterology, 2002, 123 (3) :745-750. [7]Szczepaniak LS, Nurenberg P, Leonard D, et al.Magnetic reso-nance spectroscopy to measure hepatic triglyceride content:preva-lence of hepatic steatosis in the general population[J].Am J Physiol Endocrinol Metab, 2005, 288 (2) :462-468. [8]Brunt EM.Nonalcoholic steatohepatitis[J].Semin Liver Dis, 2004, 24:3-20. [9]Guha IN, Parkes J, Roderick PR, et al.Non-invasive markers as-sociated with liver fibrosis in non-alcoholic fatty liver disease[J].Gut, 2006, 55 (11) :1650-1660. [10]El Serag HB, Tran B, Everhart JE.Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma[J].Gastroenter-ology, 2004, 126 (2) :460-468. [11]Wong VWS, Hui AY, Tsang SWC, et al.Prevalence of undiag-nosed diabetes and post-challenge hyperglycemia in Chinese pa-tients with nonalcoholic fatty liver disease[J].Aliment Pharmacol T-her, 2006, 24 (8) :1215-1222. [12]Wong VWS, Hui AY, Tsang SWC, et al.Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease[J].Clin Gastroenterol Hepatol, 2006, 4 (9) :1154-1161. [13]Omagari K, Kadokawa Y, Masuda J, et al.Fatty liver in non-al-coholic non-overweight Japanese adults:incidence and clinical characteristics[J].J Gastroenterol Hepatol, 2002, 17 (10) :1098-1105. [14]Mofrad P, Contos MJ, Haque M, et al.Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALTvalues[J].Hepatology, 2003, 37 (6) :1286-1292. [15]Wong VWS, Wong GLH, Tsang SWC, et al.Metabolic and histo-logical features of nonalcoholic fatty liver disease patients with differ-ent serum alanine aminotransferase levels[J].Aliment Pharmacol, Ther2009, 29 (4) :387-396. [16]Lee JY, KimKM, Lee SG, et al.Prevalence and risk factors of non-alcoholic fatty liver disease in potential liver donors in Korea:a re-view of589consecutive liver biopsies in a single center[J].J Hepa-tol, 2007, 47 (2) :239-244. [17]Hui AY, Wong VWS, Chan HLY, et al.Histological progression of nonalcoholic fatty liver disease in Chinese patients[J].Aliment Pharmacol Ther, 2005, 21 (4) :407-413. [18]Sebastiani G, Alberti A.Non-invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy[J].World J Gastroen-terol, 2006, 12 (23) :3682-3694. [19]Castera L.Transient elastography and other noninvasive tests to as-sess hepatic fibrosis in patients with viral hepatitis[J].J Hepatol, 2009, 16 (5) :300-314. [20]Harrison SA, Oliver D, Arnold HL, et al.Development and valida-tion of a simple NAFLD clinical scoring systemfor identifying patients without advanced fibrosis[J].Gut, 2008, 57 (10) :1441-1447. [21]Angulo P, Hui JM, Marchesini G, et al.The NAFLD fibrosis score:a noninvasive system that identifies liver fibrosis in patients with NAFLD[J].Hepatology, 2007, 45 (4) :846-854. [22]Shah AG, Lydecker A, Murray K, et al.Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease[J].Clin Gastroenterol Hepatol, 2009, 7 (10) :1104-1112. [23]Wong VWS, Wong GLH, Chim AML, et al.Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis[J].Am J Gastroenterol, 2008, 103 (7) :1682-1688. [24]WHO expert consultation.Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies[J].Lancet, 2004, 363 (9403) :157-163. [25]Talwalkar JA, Kurtz DM, Schoenleber SJ, et al.Ultrasound-based transient elastography for the detection of hepatic fibrosis:sys-tematic review and meta-analysis[J].Clin Gastroenterol Hepatol, 2007, 5 (10) :1214-1220. [26]Wong VWS, Vergniol J, Wong GLH, et al.Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease[J].Hepatology, 2010, 51 (2) :454-462. -
本文二维码
计量
- 文章访问数: 1914
- HTML全文浏览量: 5
- PDF下载量: 891
- 被引次数: 0
下载:
